These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14757770

  • 21. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A, Anders S, Catone N, Rößler P, Stotz S, Berg A, Schwab R, Scheuermann S, Bialas J, Schütz-Stoffregen MC, Schmidtke G, Peter C, Groettrup M, Wiesner S.
    Nat Commun; 2018 Aug 20; 9(1):3321. PubMed ID: 30127417
    [Abstract] [Full Text] [Related]

  • 22. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J, Groettrup M, Aichem A.
    PLoS One; 2015 Aug 20; 10(3):e0120329. PubMed ID: 25768649
    [Abstract] [Full Text] [Related]

  • 23. The ubiquitin-like modifier FAT10 - much more than a proteasome-targeting signal.
    Aichem A, Groettrup M.
    J Cell Sci; 2020 Jul 21; 133(14):. PubMed ID: 32719056
    [Abstract] [Full Text] [Related]

  • 24. Interaction of NUB1 with the proteasome subunit S5a.
    Tanji K, Tanaka T, Kamitani T.
    Biochem Biophys Res Commun; 2005 Nov 11; 337(1):116-20. PubMed ID: 16171779
    [Abstract] [Full Text] [Related]

  • 25. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis.
    Tanaka T, Yeh ET, Kamitani T.
    Eur J Biochem; 2004 Mar 11; 271(5):972-82. PubMed ID: 15009209
    [Abstract] [Full Text] [Related]

  • 26. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.
    Buchsbaum S, Bercovich B, Ciechanover A.
    Mol Biol Cell; 2012 Jan 11; 23(1):225-32. PubMed ID: 22072791
    [Abstract] [Full Text] [Related]

  • 27. The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in cellulo.
    Oliveri F, Keller SJ, Goebel H, Alvarez Salinas GO, Basler M.
    Life Sci Alliance; 2023 Jun 11; 6(6):. PubMed ID: 37012049
    [Abstract] [Full Text] [Related]

  • 28. Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome.
    Elsasser S, Chandler-Militello D, Müller B, Hanna J, Finley D.
    J Biol Chem; 2004 Jun 25; 279(26):26817-22. PubMed ID: 15117949
    [Abstract] [Full Text] [Related]

  • 29. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes.
    Whitby FG, Xia G, Pickart CM, Hill CP.
    J Biol Chem; 1998 Dec 25; 273(52):34983-91. PubMed ID: 9857030
    [Abstract] [Full Text] [Related]

  • 30. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A, Boehm AN, Catone N, Schmidtke G, Groettrup M.
    Methods Enzymol; 2019 Dec 25; 618():229-256. PubMed ID: 30850054
    [Abstract] [Full Text] [Related]

  • 31. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.
    Ebstein F, Lehmann A, Kloetzel PM.
    Cell Mol Life Sci; 2012 Jul 25; 69(14):2443-54. PubMed ID: 22349260
    [Abstract] [Full Text] [Related]

  • 32. The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway.
    Bett JS, Kanuga N, Richet E, Schmidtke G, Groettrup M, Cheetham ME, van der Spuy J.
    PLoS One; 2012 Jul 25; 7(2):e30866. PubMed ID: 22347407
    [Abstract] [Full Text] [Related]

  • 33. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome.
    Kleijnen MF, Alarcon RM, Howley PM.
    Mol Biol Cell; 2003 Sep 25; 14(9):3868-75. PubMed ID: 12972570
    [Abstract] [Full Text] [Related]

  • 34. Degradation of Id proteins by the ubiquitin-proteasome pathway.
    Bounpheng MA, Dimas JJ, Dodds SG, Christy BA.
    FASEB J; 1999 Dec 25; 13(15):2257-64. PubMed ID: 10593873
    [Abstract] [Full Text] [Related]

  • 35. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S, Fu QS, Zhao J, Hu HY.
    Biochim Biophys Acta; 2013 Dec 25; 1834(12):2672-8. PubMed ID: 24100225
    [Abstract] [Full Text] [Related]

  • 36. Plasticity of the proteasome-targeting signal Fat10 enhances substrate degradation.
    Negi H, Ravichandran A, Dasgupta P, Reddy S, Das R.
    Elife; 2024 Jul 10; 13():. PubMed ID: 38984715
    [Abstract] [Full Text] [Related]

  • 37. FAT10 inhibits TRIM21 to down-regulate antiviral type-I interferon secretion.
    Saxena K, Inholz K, Basler M, Aichem A.
    Life Sci Alliance; 2024 Sep 10; 7(9):. PubMed ID: 38977311
    [Abstract] [Full Text] [Related]

  • 38. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G, Groettrup M.
    Nat Commun; 2010 May 04; 1():13. PubMed ID: 20975683
    [Abstract] [Full Text] [Related]

  • 39. Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy.
    Tanaka T, Nakatani T, Kamitani T.
    Curr Pharm Des; 2013 May 04; 19(22):4131-9. PubMed ID: 23181574
    [Abstract] [Full Text] [Related]

  • 40. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A, Catone N, Groettrup M.
    FEBS J; 2014 Apr 04; 281(7):1848-59. PubMed ID: 24528925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.